"I hardly recognized the buoyant person I’d become," says this New York Times opinion piece writer on her experience treating her severe depression with Ketamine.
We seem to have entered a new normal for COVID. COVID doesn't seem to be leaving anytime soon, and people continue to get infected. However, symptoms are generally manageable and mild, and hospitalizations and deaths are still quite low. Politics aside, compare when President Trump got COVID (had a drop in oxygen, was seriously ill, had to be hospitalized and did well due to multiple treatments not yet available to the public) to President Biden's recent COVID illness (mild symptoms, taking Paxlovid available to everyone, stayed in the White House and continued to work). While COVID is still around, we have truly come a long way, mostly due to vaccines, boosters, and treatments like Paxlovid. Thus, with many people still getting COVID; patients, friends, and family are asking me about taking Paxlovid when they test positive.
You Might Also Enjoy...
"I hardly recognized the buoyant person I’d become," says this New York Times opinion piece writer on her experience treating her severe depression with Ketamine.
New medications have recently become available to help patients lose weight when combined with diet and exercise.
With vaccines, boosters, and treatments currently available, it's time for those who are still COVID hesitant to get back to their normal lives.
While we are still in the middle of a pandemic, it's important to keep your lungs as healthy as possible.
Warnings about limiting activity are not an over-reaction. This is a serious and deadly disease and we need to change our activities, no matter how difficult.
Spravato (nasal esketamine) is a new treatment for patients who have tried multiple medications, but failed to find relief (known as treatment resistant depression).